Latest News
-
Form of natural hormone might prevent sarcopenia
A possible new treatment has been identified to restore the common age-related loss of muscle mass and strength. Read more
-
UK alcohol report looks at harm to men
Efforts to reduce alcohol consumption among men need to confront the extent to which it is bound up with male identity in the UK, a report says today. Read more
-
Genotype testing improves paediatric asthma care
Personalising treatments according to genetic differences could help some children with asthma, a medical congress will hear today (8 September 2020). Read more
-
Vaccines may not be silver bullet
Experts have warned against excessive optimism over COVID-19 vaccines – with one senior scientist warning they would not be a “silver bullet.” Read more
-
Link found between genes and penicillin allergy
A link between genes and penicillin allergy has been discovered by an international team of scientists. Read more
-
World falling behind on non-communicable diseases
Most of the world is falling behind on promises to tackle chronic and non-communicable diseases – and the COVID-19 pandemic has made this worse, according to a major analysis. Read more
-
Social smokers face disproportionate lung disease and cancer risk
So-called “social smokers” are more than twice as likely to die of lung disease and more than eight times as likely to die from lung cancer than non-smokers, a European conference hears today. Read more
-
Common drugs could increase risk of cognitive decline
A common class of drugs could be associated with an increased risk of cognitive decline, a US study has claimed. Read more
-
Immunotherapy hope for aggressive pancreatic cancer
An aggressive form of pancreatic cancer could respond to immunotherapy, according to a study published today. Read more
-
New drug option for heart disease prevention
The common gout medication, colchicine, may help prevent major cardiovascular events in patients with chronic coronary disease, a European conference has heard. Read more